AIDX · Company research
20/20 Biolabs, Inc. Common Stock (AIDX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableOther
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.352451 | $4,690,726.85 | 144586.8534 | — | — | — | 6.4206310589935817 | 1.4847323696834876 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.